MarketScreener Strategies Perspective Therapeutics, Inc.
Stocks
CATX
US46489V3024
Biotechnology & Medical Research
|
Market Closed -
NYSE
04:00:00 29/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 3.110 USD | -2.20% |
|
-5.76% | +13.09% |
| 08-19 | BMO Capital Initiates Perspective Therapeutics at Outperform | MT |
| 08-14 | BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6 | MT |
MarketScreener Strategies
Search
No results match your criteria
- Stock Market
- Stocks
- CATX Stock
- News Perspective Therapeutics, Inc.
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
